Product Images Methylprednisolone Sodium Succinate

This is a medication label for MethyIPREDNISolone Sodium Succinate for Injection, USP manufactured by AUROMEDICS. The label includes information about the NDC code, dosage, reconstitution, and proper storage of the medication. It also indicates that the medication is for injection and is intended for either intramuscular or intravenous use only.*

This is a description of a medication, specifically a type of steroid called MethylPREDNISolone Sodium Succinate. It comes in a package of 25 single dose vials, each containing 40mg of the medication. This medication can be used through intravenous or intramuscular injection. The vials should be stored at a controlled room temperature and protected from light. The medication contains a preservative called benzyl alcohol, and the recommended diluents are sterile water or bacteriostatic water. The dosage should be determined by a prescribing medical professional and the formulation with benzyl alcohol should not be used on neonates. The product is manufactured by AuroMedics Pharma LLC, with offices located in Dayton, NJ.*

This is a medication prescribed only by a licensed healthcare provider with the NDC code 55150-263-03. The dosage information is not given and the user should consult the accompanying prescribing information. The medication, MethylPREDNISolone, should be protected from light and any unused portion should be discarded. It is a sodium succinate in the form of injection that comes in a lyophilized single-dose vial. This product is manufactured in India for AuroMedics Pharma LLC.*

This appears to be a description of a medication named MethylPREDNISolone Sodium Succinate which is used for intramuscular or intravenous use. The medication comes in a package with 25 single dose vials which must be kept in a controlled room temperature and protected from light. The recommended diluents are Water for Injection USP or Bacteriostatic Water for Injection USP. The medication contains Benzyl Alcohol 2% as a preservative. Each vial contains Methypredisolone Sodium Succinate USP, Monobasic Sodium Phosphate Anhydrous, and Dibasic Sodium Phosphate Heptahydrate. The dosages and other necessary information can be obtained from accompanying prescribing information. There is also information regarding the manufacturers and lot number.*

This is a description of a medicine called MethylPREDNISolone Sodium Succinate for Injection, USP intended for intravenous or intramuscular use only. It comes in a lyophilized multi-dose form and must be stored at a temperature between 20° and 25°C (68° to 77°F) to protect it from light. It needs to be reconstituted with Bacteriostatic Water for Injection USP with Benzyl Alcohol and diluted before administration. The recommended diluent contains Benzyl Alcohol as a preservative, and the drug should not be used on neonates. After reconstitution, the concentration is 62.5mg per mL, and the usual dosage can be found in the accompanying prescribing information. This medication is created for AuroMedics Pharma in India.*

This is a package insert for Methylprednisolone Sodium Succinate injection, USP that contains 500mg per vial, intended for intramuscular or intravenous use only. It comes in a non-pyrogenic multiple-dose vial and requires reconstitution with 8mL of Bacteriostatic water for injection USP with Benzyl alcohol. The solution should be stored at 20° to 25°C and protected from light, and used within 48 hours after mixing. The usual dosage should be determined according to its accompanying prescribing information. The formulation should not be used in neonates. The vial stoppers are not made with natural rubber latex. The package does not contain any diluent. It is manufactured for AuroMedics Pharma and manufactured by Aurobindo Pharma Limited in India.*

This is a prescription medication in a single dose vial that should be stored at room temperature between 20° to 25°C (68° to 77°F) and protected from light. It should be reconstituted with 30 ml of bacteriostatic water for injection USP and used within 48 hours after mixing. This medicine contains methylprednisolone sodium succinate USP and should only be used for intravenous or intramuscular use. The recommended diluent contains Benzyl Alcohol as a preservative. This medication should not be used for neonates.*

MethylPREDNISolone Sodium Succinate for Injection, USP is a medication for intravenous or intramuscular use only, containing 2 grams of methylprednisolone sodium succinate USP. To reconstitute it, 30mL of bacteriostatic water for injection USP is needed. It should be stored between 20-25°C and protected from light. It is recommended to use this medication within 48 hours of mixing the solution, and unused portions should be discarded. Additionally, neonates should not be treated with this formulation. The vials are non-pyrogenic and sterile, with lyophilized contents. The package does not contain a diluent, but Bacteriostatic Water for Injection (with benzyl alcohol as a preservative) is recommended for reconstitution. The vial stoppers are not made of natural rubber latex. Manufactured for AuroMedics Pharma LLC, it should be used as directed by a physician.*